Menu
GeneBe

rs2915960

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP2BP4_StrongBP6_Very_StrongBS1

The NM_000540.3(RYR1):c.9353C>T(p.Ala3118Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000299 in 1,614,068 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★). Synonymous variant affecting the same amino acid position (i.e. A3118A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0018 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00015 ( 2 hom. )

Consequence

RYR1
NM_000540.3 missense

Scores

4
13

Clinical Significance

Benign reviewed by expert panel U:1B:9

Conservation

PhyloP100: 3.47
Variant links:
Genes affected
RYR1 (HGNC:10483): (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

PP2
Missense variant where missense usually causes diseases, RYR1
BP4
Computational evidence support a benign effect (MetaRNN=0.00846836).
BP6
Variant 19-38512364-C-T is Benign according to our data. Variant chr19-38512364-C-T is described in ClinVar as [Benign]. Clinvar id is 329088.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr19-38512364-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00177 (270/152338) while in subpopulation AFR AF= 0.00625 (260/41568). AF 95% confidence interval is 0.00563. There are 1 homozygotes in gnomad4. There are 134 alleles in male gnomad4 subpopulation. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RYR1NM_000540.3 linkuse as main transcriptc.9353C>T p.Ala3118Val missense_variant 63/106 ENST00000359596.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RYR1ENST00000359596.8 linkuse as main transcriptc.9353C>T p.Ala3118Val missense_variant 63/1065 NM_000540.3 A2P21817-1
RYR1ENST00000355481.8 linkuse as main transcriptc.9353C>T p.Ala3118Val missense_variant 63/1051 P4P21817-2
RYR1ENST00000594335.5 linkuse as main transcriptc.*96C>T 3_prime_UTR_variant, NMD_transcript_variant 23/491
RYR1ENST00000599547.6 linkuse as main transcriptc.*112C>T 3_prime_UTR_variant, NMD_transcript_variant 62/802

Frequencies

GnomAD3 genomes
AF:
0.00177
AC:
269
AN:
152220
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00625
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000482
AC:
121
AN:
251032
Hom.:
1
AF XY:
0.000390
AC XY:
53
AN XY:
135748
show subpopulations
Gnomad AFR exome
AF:
0.00592
Gnomad AMR exome
AF:
0.000636
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000146
AC:
213
AN:
1461730
Hom.:
2
Cov.:
34
AF XY:
0.000116
AC XY:
84
AN XY:
727184
show subpopulations
Gnomad4 AFR exome
AF:
0.00445
Gnomad4 AMR exome
AF:
0.000626
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000108
Gnomad4 OTH exome
AF:
0.000397
GnomAD4 genome
AF:
0.00177
AC:
270
AN:
152338
Hom.:
1
Cov.:
32
AF XY:
0.00180
AC XY:
134
AN XY:
74496
show subpopulations
Gnomad4 AFR
AF:
0.00625
Gnomad4 AMR
AF:
0.000588
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000327
Hom.:
0
Bravo
AF:
0.00173
ESP6500AA
AF:
0.00454
AC:
20
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000519
AC:
63

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:9
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesJun 24, 2016- -
Likely benign, criteria provided, single submitterclinical testingGeneDxAug 13, 2019- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenDec 01, 2023RYR1: PP3, BS1 -
Malignant hyperthermia, susceptibility to, 1 Benign:2
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaAug 14, 2019This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Benign, reviewed by expert panelcurationClinGen Malignant Hyperthermia Susceptibility Variant Curation Expert Panel, ClinGenMar 17, 2021This pathogenicity assessment is relevant only for malignant hyperthermia susceptibility (MHS) inherited in an autosomal dominant pattern. Variants in RYR1 can also cause other myopathies inherited in an autosomal dominant pattern or in an autosomal recessive pattern. Some of these disorders may predispose individuals to malignant hyperthermia. RYR1 variants may also contribute to a malignant hyperthermia reaction in combination with other genetic and non-genetic factors and the clinician needs to consider such factors in making management decisions. This sequence variant predicts a substitution of Alanine with Valine at codon 3118 of the RYR1 protein, p.(Ala3118Val). The maximum allele frequency for this variant among the six major gnomAD populations is AFR: 0.0063, which is considered to be too common for a pathogenic variant causing autosomal dominantly inherited MHS, BA1. This variant has been classified as Benign. Criteria implemented: BA1. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 12, 2016- -
Congenital multicore myopathy with external ophthalmoplegia Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaAug 14, 2019This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Central core myopathy Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaAug 14, 2019This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Neuromuscular disease, congenital, with uniform type 1 fiber Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
RYR1-Related Disorders Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 29, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.10
Cadd
Pathogenic
32
Dann
Uncertain
1.0
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.37
FATHMM_MKL
Benign
0.73
D
LIST_S2
Uncertain
0.96
D;D
M_CAP
Benign
0.047
D
MetaRNN
Benign
0.0085
T;T
MetaSVM
Uncertain
-0.14
T
MutationAssessor
Benign
1.1
L;L
MutationTaster
Benign
0.89
N;N;N
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
-2.1
N;N
REVEL
Benign
0.21
Sift
Benign
0.48
T;T
Polyphen
0.030
B;B
Vest4
0.48
MVP
0.93
MPC
0.33
ClinPred
0.022
T
GERP RS
3.3
Varity_R
0.13
gMVP
0.20

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.83
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.83
Position offset: -2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2915960; hg19: chr19-39003004; COSMIC: COSV100614482; API